BioAge Labs (BIOA) Long-Term Debt Issuances (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Long-Term Debt Issuances data on file, last reported at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Debt Issuances changed 0.0% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $6.0 million (changed 0.0% YoY), and the FY2025 full-year result was $6.0 million, changed 0.0% from the prior year.
• Long-Term Debt Issuances steadied at $1.5 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $1.5 million in Q1 2024 to a low of -$11.5 million in Q4 2023.
• A 4-year average of $200000.0 and a median of $1.5 million in 2024 frame the typical range for Long-Term Debt Issuances.
• Across the five-year window, Long-Term Debt Issuances soared 113.04% in 2024 and changed 0.0% in 2025, its largest moves.
• Tracing BIOA's Long-Term Debt Issuances over 4 years: stood at -$11.5 million in 2023, then soared by 113.04% to $1.5 million in 2024, then changed by 0.0% to $1.5 million in 2025, then changed by 0.0% to $1.5 million in 2026.
• Business Quant data shows BIOA's Long-Term Debt Issuances at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.